1. Home
  2. MLGO vs SCLX Comparison

MLGO vs SCLX Comparison

Compare MLGO & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroAlgo Inc.

MLGO

MicroAlgo Inc.

HOLD

Current Price

$5.84

Market Cap

75.5M

Sector

Technology

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$11.37

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLGO
SCLX
Founded
2018
2011
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.5M
90.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MLGO
SCLX
Price
$5.84
$11.37
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
190.4K
75.9K
Earning Date
03-27-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.04
N/A
Revenue
$61,302,336.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
$1.42
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$3.60
52 Week High
$972.00
$34.27

Technical Indicators

Market Signals
Indicator
MLGO
SCLX
Relative Strength Index (RSI) 48.17 31.18
Support Level $5.19 $11.10
Resistance Level $6.38 $13.83
Average True Range (ATR) 0.52 0.99
MACD 0.13 -0.02
Stochastic Oscillator 69.80 8.28

Price Performance

Historical Comparison
MLGO
SCLX

About MLGO MicroAlgo Inc.

MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: